Publications

June 2021
Case

HelloSelf: Launch

By: John R. Wells and Benjamin Weinstock

In April 2021, Charles Wells, founder and CEO of HelloSelf was reflecting on the company’s progress since it launched two years earlier. HelloSelf’s goal was to help the mentally ill recover and those who were mentally fit to stay well and feel even better. To do this,... View Details

Keywords: Mental Health; Health Care and Treatment; Internet and the Web; Growth and Development Strategy; Great Britain

12 Feb 2008
First Look

First Look: February 12, 2007

arises from a major economic, social, and institutional breakdown that jeopardizes the subsidiary's existence. Argentina defaulted on it sovereign debt and devalued the peso by over 200%, but it differentiated the treatment View Details

Keywords: Martha Lagace

06 Sep 2006
Lessons from the Classroom

Mixing Students and Scientists in the Classroom

of quantum dots for cancer treatment that had been proposed by an outside sponsor. Along with a bunch of other highly qualified students, one of... View Details

Keywords: by Deborah Blagg; Education

January 2010 (Revised August 2012)
Background Note

Note on Telemedicine

By: Regina E. Herzlinger and Jillian Copeland

This note provides background in all the modalities of telemedicine. It accompanies the cases "Medtronic: Patient Management Initiative" (A) and (B), HBS Nos. 302-005 and 309-064. View Details

Keywords: Interactive Communication; Entrepreneurship; Health Care and Treatment; Technological Innovation; Information Technology; Health Industry; Telecommunications Industry

19 Feb 2019
First Look

New Research and Ideas, February 19, 2019

health-economics literature has done a better job documenting consumer-choice mistakes in insurance and treatment choices than explaining why those mistakes occur, it is clear that we should not ignore these mistakes in our analyses. We... View Details

Keywords: Sean Silverthorne

28 Apr 2010
Research & Ideas

Earth Day Reflections

Below are the views that faculty shared with the HBS community on Earth Day. 1. Robert G. Eccles Senior Lecturer of Business Administration and author of One Report: Integrated Reporting for a Sustainable... View Details

Keywords: by Staff

November 1998
Case

Wegmans Food Markets: Diabetes Counseling

By: Ray A. Goldberg, David E. Bell and Ann Leamon

Danny Wegman, president of Wegmans Food Markets, is trying to decide how to evaluate the success of a nutrition-counseling program for diabetics, and whether and how to expand the program beyond the two stores currently involved. Wegmans, with 57 stores and $2.3... View Details

Keywords: Performance Evaluation; Expansion; Programs; Human Needs; Financial Management; Health Care and Treatment; Nutrition; Consumer Behavior; Pharmaceutical Industry; Food and Beverage Industry

August 2001 (Revised February 2020)
Case

Consumer-Driven Health Care: Medtronic's Health Insurance Options

By: Regina E. Herzlinger, John Hurwitch and Seth Bokser

Describes the variety of health insurance plans that this medical device company offers, including a high-deductible, consumer-driven health plan with a health reimbursement account that also enables health care providers to quote their own prices. Asks students to... View Details

Keywords: Health Care and Treatment; Insurance; Decision Choices and Conditions; Compensation and Benefits; Demand and Consumers

November 2013
Case

GlaxoSmithKline in China (A)

By: John A. Quelch and Margaret L. Rodriguez

Four GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to... View Details

31 Jan 2012
First Look

First Look: Jan. 31

financial management and the usefulness of formal hedging of agricultural production risks was offered to randomly selected farmers in Gujarat, India. The authors evaluate the effect View Details

Keywords: Sean Silverthorne & Carmen Nobel

May 2011
Article

Nonsimultaneous Chains and Dominos in Kidney Paired Donation—Revisited

By: Itai Ashlagi, Duncan S. Gilchrist, Alvin E. Roth and Michael A. Rees

Since 2008 kidney exchange in America has grown in part from the incorporation of non-directed donors in transplant chains rather than simple exchanges. It is controversial whether these chains should be performed simultaneously ("domino paired donation," DPD) or... View Details

Keywords: ABO Incompatibility; Allosensitization; Paired Kidney Exchange; Regional Sharing; Simulation Models; Transplantation Policy; Health Care and Treatment; Supply Chain; Risk and Uncertainty; Logistics; United States

Find at Harvard

Read Now

August 2006 (Revised September 2007)
Supplement

Istituto Clinico Humanitas (C): Pronto Soccorso

By: Richard M.J. Bohmer

Follows on from the cases Istituto Clinico Humanitas (A) and (B). Describes the design and running of the new Humanitas Emergency Department. Istituto Clinico Humanitas has developed a very efficient operating system for dealing with elective (largely surgical)... View Details

Keywords: Health Care and Treatment; Organizational Change and Adaptation; Service Operations; Service Delivery; Customer Focus and Relationships; Health Industry; Italy

August 2017 (Revised July 2018)
Case

MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work

By: Elie Ofek and Amanda Dai

In June 2014, MannKind Corporation announced that after years of development and billions of dollars in expenses, the FDA had finally approved its drug, Afrezza. MannKind would thus be the only company with an inhalable insulin on the market. As an alternative to... View Details

Keywords: Health Care and Treatment; Product Launch; Product Positioning; Marketing Strategy; Adoption; Pharmaceutical Industry

March 2015 (Revised February 2022)
Supplement

CV Ingenuity (B): Epilogue

By: Regina E. Herzlinger and Andrew Otazo

Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors? The... View Details

October 2018 (Revised August 2019)
Case

Beth Israel Deaconess: Consolidating to Strengthen, or to Stave Off, Competition?

By: Leemore Dafny

In July 2017, CEO Kevin Tabb of Boston's Beth Israel Deaconess Medical Center announced his plan to consolidate 11 Massachusetts hospitals under a common management structure. These hospitals collectively generated $5 billion in patient revenue and 25% of... View Details

Keywords: Beth Israel Deaconess; Lahey; Partners; Health Care; Hospitals; Payers; Providers; Anti-trust; Health Care Regulation; Mergers and Acquisitions; Health Care and Treatment; Market Design; Duopoly and Oligopoly; Negotiation; Consolidation; Competition; Health Industry; Massachusetts; Boston

Keywords: by Blasco, Andrea, Michael G. Endres, Rinat A. Sergeev, Anup Jonchhe, Max Macaluso, Rajiv Narayan, Ted Natoli, Jin H. Paik, Bryan Briney, Chunlei Wu, Andrew I. Su, Aravind Subramanian, and Karim R. Lakhani; Health

21 Mar 2019
Working Paper Summaries

Advancing Computational Biology and Bioinformatics Research Through Open Innovation Competitions

September 1995
Case

Ares-Serono

By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop

Ares Serono, a medium-size Swiss pharmaceutical company, is the global leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech firms in Europe. The case treats a set of major strategic and organizational... View Details

Keywords: Geographic Location; Globalized Firms and Management; Asset Management; Balance and Stability; Expansion; Digital Platforms; Leadership Development; Health Care and Treatment; Transformation; Family Business; Problems and Challenges; Pharmaceutical Industry; Biotechnology Industry; Switzerland; Europe

Find at Harvard

January 2021 (Revised June 2021)
Case

Hester Pharmaceuticals (A): A Pricing Dilemma

By: Dante Roscini and John Masko

In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details

Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy